AstraZeneca announces AI deal as AstraZeneca stock trades at EUR 153.53
Published on 10/24/2026 at 10:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAI collaboration and market level
- AstraZeneca announced the insitro collaboration on October 15, 2026, with a USD 40 million upfront payment.
- AstraZeneca stock trades in weekend trading at Lang & Schwarz at EUR 153.53 at 10:29 a.m. CEST on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
AstraZeneca announced a strategic AI drug-discovery collaboration with insitro on October 15, 2026, according to the company’s press release. AstraZeneca stock trades at EUR 153.53 in weekend trading at Lang & Schwarz at 10:29 a.m. CEST on October 24, 2026.
Market context: Market report FTSE 100.
The week in figures
Lang & Schwarz showed AstraZeneca at EUR 153.53 at 10:29 a.m. CEST on October 24, 2026. The quote is a weekend-trading indication while Xetra is closed.
The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of AstraZeneca stock.
Chronology of the week
On October 15, 2026, AstraZeneca said insitro would receive a USD 40 million upfront payment under the collaboration. The agreement also provides for up to approximately USD 1.46 billion in potential development and commercial milestones, plus potential single-digit royalties, according to the company’s release.
Dates of the coming week
The next Xetra session is scheduled for October 26, 2026. AstraZeneca’s collaboration is focused on identifying drug targets and advancing potential therapies for metabolic dysfunction-associated steatohepatitis and cardiomyopathies.
